VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Oticara

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

Treatment for Chronic Rhinosinusitis - Innovative CRS Therapy by Oticara

  • Biotech & therapeutics
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Discover Oticara’s innovative treatment for chronic rhinosinusitis (CRS). ENT-delivered, single-dose steroid nasal cream providing effective symptom relief for patients where standard therapies fail.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy